Nuclear Medicine or Radiopharmaceuticals Market worth $5.70 billion by 2028


Nuclear Medicine or Radiopharmaceuticals Market size is projected to reach USD 9.52 Billion by 2028 from an estimated USD 5.70 Billion in 2021, growing at a CAGR of 7.6% globally.

The “Global Nuclear Medicine or Radiopharmaceuticals Market by Type, Application and Region – Forecast to 2028″ report has been added to Introspective Market Research offering. Growth in the nuclear medicine market can primarily be attributed to factors such as the increasing incidence and prevalence of cancer and cardiac ailments and initiatives to lessen the demand-supply gap of Mo-99. However, the short half-life of radiopharmaceuticals reduces their potential adoption, while hospital budget cuts and high equipment prices are expected to limit market growth to a certain extent.

In this report, the nuclear medicine market has been segmented based on type, application, procedure volume and region. Based on type, the nuclear medicine market is categorized into diagnostic and therapeutic nuclear medicine. The therapeutic nuclear medicine segment is further segmented into alpha emitters, beta emitters, and brachytherapy isotopes. The diagnostic nuclear medicine segment is segmented into SPECT and PET.

Key Prominent Players In The Nuclear Medicine or Radiopharmaceuticals Market:

  • Actinium Pharmaceuticals Inc. (US)
  • Alliance Medical (UK)
  • Avid Bioservices Inc (US)
  • Bayer HealthCare Pharmaceuticals (Germany)
  • Bracco Diagnostics Inc. (Italy)
  • Cardinal Health Inc. (US)
  • GE Healthcare (US)
  • Ion Beam Applications S.A (Belgium)
  • Jubilant Pharma (India)
  • Lantheus Medical Imaging Inc. (US)
  • Medi-Radiopharma Ltd (Hungary)
  • Nordion Inc. (Canada)
  • Novartis/Advanced Accelerator Applications (France)
  • Positron Corporation (US)
  • Radiopharm Theranostics Ltd. (US)

Know More About The Global Trends Impacting The Future, Download A PDF Sample@:

Market segmentation

The Nuclear Medicine or Radiopharmaceuticals market is segmented by type and application. Growth between segments over the period 2022-2028 provides accurate calculations and forecasts of revenue by type and application in terms of volume and value. This analysis can help you expand your business by targeting eligible niches.

Nuclear Medicine or Radiopharmaceuticals Market Segment by Types, Estimates, and Forecast by 2028


Nuclear Medicine or Radiopharmaceuticals Market Segment by Applications, Estimates, and Forecast by 2028

Oncology,Thyroid,Cardiology,Neurology and Others

Regional Analysis for COVID-19 Outbreak-Global Nuclear Medicine or Radiopharmaceuticals Market:

  • APAC (Japan, China, South Korea, Australia, India, and Rest of APAC)
  • Europe (Germany, UK, France, Spain, Italy, Russia, Rest of Europe)
  • North America (U.S., Canada, and Mexico)
  • South America (Brazil, Chile, Argentina, Rest of South America)
  • MEA (Saudi Arabia, UAE, South Africa)

We Offer Discount on The Nuclear Medicine or Radiopharmaceuticals Market Report @:

Industry experts have identified key factors influencing the pace of development of the Nuclear Medicine or Radiopharmaceuticals industry, including various opportunities and gaps. A thorough analysis of the Nuclear Medicine or Radiopharmaceuticals market for the growth trends of each category makes the overall study interesting. When studying the market, researchers also dig deep into their future prospects and their contribution to the industry. Additionally, the research report evaluated the market key players and features, such as capacity utilization rate comprised of revenue.

Nuclear Medicine or Radiopharmaceuticals Report provides insights into the following queries:

1.Market growth rate and growth momentum of Nuclear Medicine or Radiopharmaceuticals market for the period 2022-2028
2. The estimated size of the Nuclear Medicine or Radiopharmaceuticals market for the period 2022-2028
4. Sales (volume), revenue, and value analysis by regions of Nuclear Medicine or Radiopharmaceuticals market
5. The associated market risk, opportunity, and market overview of the Nuclear Medicine or Radiopharmaceuticals market
6. Major distributors, dealers, end-users, and traders of the Nuclear Medicine or Radiopharmaceuticals market?

Make An Inquiry For Report Customization (Must Use Business Contact Details For High Preference):

This study conducts a SWOT analysis to evaluate the strengths and weaknesses of key players in the Nuclear Medicine or Radiopharmaceuticals market. Additionally, the report performs a complex inspection of drivers and restraints operating in the market. The report also evaluates the observed trends in the parent market along with macroeconomic indicators, dominant factors and market attractiveness in relation to other segments. The report forecasts the impact of various industry aspects on the Nuclear Medicine or Radiopharmaceuticals market segments and regions.

Key Points Covered in Radiopharmaceuticals Market Study

  • Market estimates and forecast 2022-2028
  • Key drivers and restraints impacting market growth
  • Segment-wise, Country-wise, and Region-wise Analysis
  • Competition Mapping and Benchmarking
  • Brand share and Market Share Analysis
  • Key Radioisotope Innovations and Regulatory Climate
  • COVID-19 Impact on Radiopharmaceuticals market and How to Navigate
  • Recommendation on Key Winning Strategies

Read More PR:

About Us:

Introspective Market Research ( is a visionary research consulting firm dedicated to assist our clients grow and have a successful impact on the market. Our team at IMR is ready to assist our clients flourish their business by offering strategies to gain success and monopoly in their respective fields. We are a global market research company, specialized in using big data and advanced analytics to show the bigger picture of the market trends. We help our clients to think differently and build better tomorrow for all of us. We are a technology-driven research company, we analyse extremely large sets of data to discover deeper insights and provide conclusive consulting. We not only provide intelligence solutions, but we help our clients in how they can achieve their goals.

Contact Us:

Mike Cooper

Business Development Manager

3001 S King Drive, Chicago, Illinois,

U.S. A 60616

Contact No: USA: +1 (773)-382-1047 / IND: +91-81-8009-6367

Leave a reply